Estimates Revisions Ocugen, Inc. Börse Stuttgart

Stocks

Real-time Estimate Tradegate Other stock markets 15:22:51 30/07/2026 +04			5-day change	1st Jan Change
1.037 ^EUR	-0.10%		-7.98%	-18.59%

07-13	Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License Ocu400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa	CI
07-13	Ocugen Signs Term Sheet to License Retinitis Pigmentosa Gene Therapy to Roots Pharmaceutical, Al-Dhow in MENA Region	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	LONZA GROUP AG
	IQVIA HOLDINGS INC.
	REVOLUTION MEDICINES, INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	ASCENDIS PHARMA A/S			-
	MEDPACE HOLDINGS, INC.
	ICON PUBLIC LIMITED COMPANY
	EUROFINS SCIENTIFIC SE
	Average
	Weighted average by Cap.